Swift Microwave Therapy: Transforming Care in Podiatry
The treatment of stubborn skin lesions has long been a challenge for both podiatrists and dermatologists. Traditional approaches such as cryotherapy, topical treatments, acids, and surgical interventions can require multiple appointments, cause discomfort, and sometimes deliver inconsistent outcomes. Innovative microwave technology is changing that landscape, and Swift® is at the forefront of this evolution.
A New Approach to Treating HPV-Related Lesions
Developed by Scottish health technology company Emblation, Swift uses microwave energy to treat HPV-based skin lesions, including plantar warts (verrucae) and common warts. Unlike traditional destructive therapies, Swift delivers controlled microwave energy into the affected tissue, stimulating a local immune response while targeting the infected area. [alloaadvertiser.com], [scottishfi...alnews.com]
Since its launch in 2016, Swift has gained significant traction among healthcare professionals. In 2022, Emblation announced that more than 200,000 treatments had been completed worldwide, demonstrating strong adoption across podiatry and dermatology practices in the UK, Australia, Canada, and the United States. [alloaadvertiser.com]
Why Swift Appeals to Podiatric Patients
Plantar warts are among the most common reasons patients visit podiatry clinics. Many cases prove resistant to conventional therapies, leading to patient frustration and repeat appointments.
Swift offers several advantages that have contributed to its popularity:
A quick, in-clinic procedure.
No requirement for dressings after treatment.
Minimal disruption to daily activities.
A treatment option for persistent and difficult-to-treat verrucae.
According to Emblation's chief commercial officer, Swift has become an "invaluable" addition to many clinics because it is quick, easy to use, and highly effective. [alloaadvertiser.com]
Expanding Uses For Swift Therapy
While Swift first gained prominence in the treatment of plantar warts, its dermatological applications continue to expand. Emblation reports that the technology has advanced the treatment of HPV-based skin lesions, including actinic keratosis, and IPK. [scottishfi...alnews.com]
Actinic keratosis is a common precancerous skin condition that affects millions of patients worldwide. The ability of microwave technology to treat these lesions offers dermatologists an additional tool that may complement existing treatment options.
The company has also disclosed that its microwave technology is undergoing trials for the treatment of skin cancers, pre-cancers, and other conditions. [scottishfi...alnews.com]
Global Growth Reflects Clinical Demand
The success of Swift is reflected in Emblation's rapid international growth. By 2023, the company reported that more than 300,000 treatments had been performed globally. [scottishfi...alnews.com]
This momentum has supported continued investment in innovation. In 2023, Emblation moved into a new £4 million headquarters in Stirling, Scotland, featuring research, development, and manufacturing facilities designed to support the company's next phase of growth. [scottishfi...alnews.com]
The Future of Microwave-Based Skin Treatment
As healthcare providers look for effective, patient-friendly solutions for managing difficult skin lesions, microwave therapy is emerging as a compelling option. Swift's growing adoption in podiatry demonstrates how innovative technologies can improve clinical outcomes while enhancing the patient experience.
With hundreds of thousands of treatments already completed and ongoing research into additional dermatological applications, Swift appears well positioned to play an increasingly important role in the future of skin lesion management. [alloaadvertiser.com], [scottishfi...alnews.com]
Sources
Clacks-based Emblation passes major treatment milestone, Alloa and Hillfoots Advertiser.
Emblation settles into new £4m Stirling HQ, Scottish Financial News.